Viewing Study NCT00002495


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2025-12-27 @ 10:35 PM
Study NCT ID: NCT00002495
Status: COMPLETED
Last Update Posted: 2017-02-20
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
Sponsor: SWOG Cancer Research Network
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module